Direct Measurement of Peptide-Specific CD8+ T Cells Using HLA-A2:Ig Dimer for Monitoring the In Vivo Immune Response to a HER2/neu Vaccine in Breast and Prostate Cancer Patients

By Woll Michael M.   Fisher Christine M.   Ryan Gayle B.   Gurney Jennifer M.   Storrer Catherine E.   Ioannides Constantin G.   Shriver Craig D.   Moul Judd W.   Mcleod David G.   Ponniah Sathibalan   Peoples George E.  

Journal of Clinical Immunology, Vol. 24, Iss. 4, 2004-07 ,pp. : 449-461

Springer Publishing Company

Access to resources Recommend Favorite

Extended trastuzumab therapy improves the survival of HER2positive breast cancer patients following surgery and radiotherapy for brain metastases

By                            

Molecular and Clinical Oncology, Vol. 1, Iss. 6, 2013-01 ,pp. : 995-1001

Spandidos Publications

Access to resources Recommend Favorite

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

By Ribas A.   Timmerman J.M.   Butterfield L.H.   Economou J.S.  

Trends in Immunology, Vol. 24, Iss. 2, 2003-02 ,pp. : 58-61

Elsevier

Access to resources Recommend Favorite

Fluorescence in Situ Hybridization Study of HER-2/neu Oncogene Amplification in Prostate Cancer

By Mark H.F.L.   Feldman D.   Das S.   Kye H.   Mark S.   Sun C.-L.   Samy M.  

Experimental and Molecular Pathology, Vol. 66, Iss. 2, 1999-06 ,pp. : 170-178

Elsevier

Access to resources Recommend Favorite

Fluorescence in Situ Hybridization Analysis of HER-2/neu, c-myc, and p53 in Endometrial Cancer

By Williams J.A.   Wang Z.-R.   Parrish R.S.   Hazlett L.J.   Smith S.T.   Young S.R.  

Experimental and Molecular Pathology, Vol. 67, Iss. 3, 1999-12 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite